Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
CD19/CD22 dual-target CAR-T / Shenzhen University General Hospital
CAR-T, NCT04723901: Dual Target Cells in B-cell Acute Lymphoblastic Leukemia	Recruiting	1/2	20	RoW	Dual target CAR-T cell therapy	Shenzhen University General Hospital	Dual-target CAR-T Cells, B ALL, Relapse, Refractory B Acute Lymphoblastic Leukemia	12/22	12/22